Vitalitas Denver
  • Home
  • About
    • Why Us?
  • Conditions
    • Ketamine for Depression
    • Anxiety Treatments
    • PTSD Treatments
    • Bipolar Disorder Treatments
    • Ketamine for Chronic Pain
    • Migraine Medicine
  • IV Hydration
  • Pricing
  • FAQs
  • Blog
  • Research
  • Start a Clinic
  • For Patients
  • Contact
    • Service Areas
Select Page
Spravato is FDA-Approved…and Here’s What You Need to Know

Spravato is FDA-Approved…and Here’s What You Need to Know

by Roman Langston | Apr 3, 2019 | Blog, Popular

The recent FDA approval of the use of esketamine for treatment-resistant depression means many Americans suffering will soon find relief. The drug, Spravato, was approved for patients who have failed to respond at all to at least two other antidepressant medications....
The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

by Roman Langston | Feb 26, 2019 | Blog, Popular

Since it was developed in 2016, we’ve blogged several times about esketamine—the isomer of ketamine being developed by Janssen Pharmaceuticals, designed to rapidly alleviate the symptoms of treatment-resistant depression. Esketamine, which will be administered...

Recent Posts

  • New Year, New Goals, Same Me
  • What Causes Dementia, and Could It Be Linked to Depression?
  • Holiday Depression: 6 Depression Symptoms to Watch Out For

Subscribe to our Blog

Get Social With Us

Categories

  • Blog
  • Depression Treatment
  • Featured
  • Ketamine for Chronic Pain
  • Ketamine for Covid-19
  • Ketamine for Depression
  • Ketamine for PTSD
  • Ketamine Infusion Therapy
  • Mental Health
  • Popular
  • Treatments for Anxiety
  • Uncategorized
  • Facebook
  • Twitter
  • Instagram
  • RSS
Site developed by Birdhouse Marketing & Design